REPLIMUNE GROUP INC. - COMMON STOCK
8.9800
30-May-25 13:45:00
15 minutes delayed
Stocks
-0.3900
-4.16%
Today's range
8.6100 - 9.3500
ISIN
N/A
Source
NASDAQ
-
Replimune to Present at the 42nd Annual J.P. Morgan Healthcare Conference
28 Dec 2023 05:00:00 By Nasdaq GlobeNewswire
-
08 Nov 2023 06:10:00 By Nasdaq GlobeNewswire
-
Replimune Reports Fiscal Second Quarter 2024 Financial Results and Provides Corporate Update
07 Nov 2023 05:00:01 By Nasdaq GlobeNewswire
-
03 Nov 2023 16:30:00 By Nasdaq GlobeNewswire
-
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
19 Sep 2023 13:01:00 By Nasdaq GlobeNewswire
-
Replimune Announces Appointment of Emily Hill as Chief Financial Officer
19 Sep 2023 05:00:00 By Nasdaq GlobeNewswire
-
Replimune Reports Fiscal First Quarter 2024 Financial Results and Provides Corporate Update
03 Aug 2023 05:00:01 By Nasdaq GlobeNewswire
-
Replimune to Present at Two Upcoming Investor Conferences
01 Aug 2023 05:00:00 By Nasdaq GlobeNewswire
-
Replimune Announces Sander Slootweg will Depart from its Board of Directors
20 Jul 2023 05:00:01 By Nasdaq GlobeNewswire
-
06 Jun 2023 07:00:00 By Nasdaq GlobeNewswire
-
Replimune Appoints Veleka R. Peeples-Dyer to its Board of Directors
05 Jun 2023 05:00:00 By Nasdaq GlobeNewswire
-
03 Jun 2023 11:15:00 By Nasdaq GlobeNewswire
-
Replimune to Present at the Jefferies Global Healthcare Conference
01 Jun 2023 13:01:00 By Nasdaq GlobeNewswire
-
Replimune to Present at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
25 May 2023 14:00:00 By Nasdaq GlobeNewswire
-
18 May 2023 05:00:00 By Nasdaq GlobeNewswire
-
Replimune to Participate in the Piper Sandler Spring Biopharma Symposium
09 May 2023 05:00:01 By Nasdaq GlobeNewswire
-
Replimune to Present at Two Upcoming Investor Conferences
08 Mar 2023 05:00:01 By Nasdaq GlobeNewswire
-
Replimune Reports Fiscal Third Quarter Financial Results and Provides Corporate Update
09 Feb 2023 05:00:01 By Nasdaq GlobeNewswire
-
Replimune to Present at the Virtual SVB Securities Global Biopharma Conference
07 Feb 2023 05:00:02 By Nasdaq GlobeNewswire